We are live on ! Find out more
GILD icon

Gilead Sciences

1,575 hedge funds and large institutions have $73.2B invested in Gilead Sciences in 2017 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 535 increasing their positions, 691 reducing their positions, and 116 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 202 | Existing positions closed: 116

5% more funds holding

Funds holding: 1,5041,575 (+71)

1.25% more ownership

Funds ownership: 76.99%78.25% (+1.3%)

10% less capital invested

Capital invested by funds: $81.5B → $73.2B (-$8.37B)

23% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 691

40% less call options, than puts

Call options by funds: $1.57B | Put options by funds: $2.63B

46% less funds holding in top 10

Funds holding in top 10: 9652 (-44)

Holders
1,575
Holders Change
+71
Holders Change %
+4.72%
% of All Funds
35.71%
Holding in Top 10
52
Holding in Top 10 Change
-44
Holding in Top 10 Change %
-45.83%
% of All Funds
1.18%
New
202
Increased
535
Reduced
691
Closed
116
Calls
$1.57B
Puts
$2.63B
Net Calls
-$1.06B
Net Calls Change
-$328M
Name Holding Trade Value Shares
Change
Change in
Stake
WMSA
1601
Weiss Multi-Strategy Advisers
New York
-$4.05M -50,000 Closed
3C
1602
361 Capital
Colorado
-$4.03M -49,772 Closed
PA
1603
Perceptive Advisors
New York
-$3.24M -40,000 Closed
SCM
1604
Stanley Capital Management
Texas
-$3.1M -38,275 Closed
LA
1605
Lau Associates
Delaware
-$2.75M -34,000 Closed
OCM
1606
One Capital Management
California
-$2.7M -33,274 Closed
AGAM
1607
Avalon Global Asset Management
California
-$2.43M -30,000 Closed
ECM
1608
Endurant Capital Management
California
-$2.22M -27,357 Closed
MWVC
1609
Morgens Waterfall Vintiadis & Co
New York
-$2.03M -25,000 Closed
ICOA
1610
Investment Centers of America
North Dakota
-$1.8M -22,318 Closed
RAM
1611
Redmond Asset Management
Virginia
-$1.73M -21,310 Closed
Marshall Wace
1612
Marshall Wace
United Kingdom
-$1.42M -17,562 Closed
IAM
1613
Integre Asset Management
New York
-$1.38M -17,064 Closed
FAM
1614
Fortaleza Asset Management
Illinois
-$1.29M -15,900 Closed
BCM
1615
Bayesian Capital Management
New York
-$1.24M -15,300 Closed
PAWC
1616
P.A.W. Capital
Connecticut
-$1.22M -15,000 Closed
DCM
1617
Dimension Capital Management
Florida
-$1.18M -14,602 Closed
NPC
1618
National Planning Corporation
California
-$1.14M -14,038 Closed
TI
1619
Trexquant Investment
Connecticut
-$973K -12,010 Closed
SAS
1620
Stelac Advisory Services
New York
-$867K -10,707 Closed
HJMC
1621
Hellman Jordan Management Company
Massachusetts
-$829K -10,228 Closed
AGM
1622
Alpine Global Management
New York
-$806K -9,949 Closed
RC
1623
Roundview Capital
New Jersey
-$724K -8,934 Closed
GI
1624
Glovista Investments
New Jersey
-$610K -7,535 Closed
PWPCM
1625
Perella Weinberg Partners Capital Management
New York
-$561 -6,928 Closed

GILD Hedge Fund Activity: Q4 2017 in Review

1,575 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2017, worth a combined $73.2B — down 10% from $81.5B a quarter earlier.

Buyers outnumbered sellers: 202 funds opened new GILD positions and 116 closed out — a net gain of 86 holders — while 535 added to existing stakes and 691 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $794M. The largest seller was C WorldWide Group, cutting an estimated $300M.

  • 1,575 institutional investors held Gilead Sciences (GILD) as of Q4 2017, up from 1,504 in Q3 2017.
  • Funds reported $73.2B of Gilead Sciences stock for Q4 2017, down 10% quarter-over-quarter.
  • 202 funds opened new Gilead Sciences positions in Q4 2017 and 116 closed out, a net change of +86 holders.
  • The largest Gilead Sciences buyer in Q4 2017 was Capital Research Global Investors, an estimated $794M added.
  • The largest Gilead Sciences seller in Q4 2017 was C WorldWide Group, an estimated $300M sold.

Based on aggregated 13F filings for Q4 2017.